Latest Retinitis pigmentosa Stories
Scientists use a new technique consisting of the induction of neuronal degeneration for intense light exposure in the mouseâ€™s retina, an experimental model of retinitis pigmentosa
Research lead by Dr. Nicolas Bazan, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans
Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for human clinical trials.
Walkers Raised $3000 to Help Fund Sight-Saving Research Through Foundation Fighting Blindness DALLAS, June 10 /PRNewswire/ -- Principal Management Group of North Texas (PMG), an Associa Company, recently participated in a walk-a-thon as "Bonnie Believers" in support of the Greater DFW Chapter of the Foundation Fighting Blindness, Inc.
LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP).
Stem cells taken from bone marrow show promise in healing damaged retinal tissue, said researchers at the University of Louisville in Kentucky. The stem cells generated new cells in damaged retinal pigment epithelium, the pigmented cell layer just outside the retina, research led by Dr.
The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease â€“ the features or disorders associated with it â€“ vary in type and severity among those who are affected. Scientists, physicians and patients all ask why.
WASHINGTON, April 29 /PRNewswire/ -- Vision loss is a high priority area for VA Research.
Omega three fatty acids protect brain cells by preventing the misfolding of a protein from a gene mutation in Parkinson's disease, U.S. researchers said. Dr. Nicolas Bazan of Louisiana State University and colleagues developed a cell model with a mutation of the Ataxin-1 gene.
Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans,